CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 3,922	$ 4,231	$ 3,339
Cost of products sold	1,795	1,884	1,683
Gross profit	2,127	2,347	1,656
Selling, general, and administrative expenses	1,589	1,551	1,302
Research and development expenses	174	171	123
Goodwill impairment	1,187	0	157
Intangible asset impairment and other costs	114	17	77
Operating (loss) income	(937)	608	(3)
Other income and expenses:
Interest expense, net	60	55	46
Other expense (income), net	58	8	1
(Loss) income before income taxes	(1,055)	545	(50)
(Benefit) provision for income taxes	(105)	134	23
Net (loss) income	(950)	411	(73)
Less: Net income (loss) attributable to noncontrolling interests	0	0	0
Net (loss) income attributable to Dentsply Sirona	$ (950)	$ 411	$ (73)
Net (loss) income per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ (4.41)	$ 1.88	$ (0.33)
Diluted (in dollars per share)	$ (4.41)	$ 1.87	$ (0.33)
Weighted average common shares outstanding:
Basic (in shares)	215.5	218.4	219.2
Diluted (in shares)	215.5	220.2	219.2